AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 290: E840-E848, 2006. First published December 6, 2005; doi:10.1152/ajpendo.00458.2005
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/E840    most recent
00458.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billet, S.
Right arrow Articles by Conchon, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billet, S.
Right arrow Articles by Conchon, S.

The AT1A receptor "gain-of-function" mutant N111S/{Delta}329 is both constitutively active and hyperreactive to angiotensin II

Sandrine Billet, Sabine Bardin, Rachida Tacine, Eric Clauser, and Sophie Conchon

Département d'Endocrinologie, Institut Cochin; Institut National de la Santé et de la Recherche Médicale, U567; Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104; and Faculté de Médecine René Descartes, Université Paris Descartes, Unité Mixte de Recherche et de Service 8104, Paris, France

Submitted 21 September 2005 ; accepted in final form 30 November 2005

The renin-angiotensin-aldosterone system (RAAS) is central to cardiovascular and renal physiology. However, there is no animal model in which the activation of the RAAS only reflects the activation of the angiotensin II (ANG II) AT1 receptor. As a first step to developing such a model, we characterized a gain-of-function mutant of the mouse AT1A receptor. This mutant carries two mutations: N111S predicted to activate the receptor constitutively and a COOH-terminal deletion, {Delta}329, expected to reduce receptor internalization and desensitization. We expressed this double mutant (AT1A-N111S/{Delta}329) in heterologous cells. It showed a pharmacological profile consistent with that of other constitutively active mutants. Furthermore, it increased basal production of inositol phosphates, as well as basal cytosolic and nuclear ERK activities. Basal proliferation of cells expressing the mutant was also greater than that of the wild type. The double mutant was poorly internalized and failed to recruit beta-arrestin 2 in the presence of ANG II. It also showed hypersensitive and hyperreactive responses to ANG II for both inositol phosphate production and ERK activation. The additivity of the phenotypes of the two mutations makes this mutant an appropriate candidate to test the physiological consequences of the AT1A receptor activation itself in transgenic animal models.

G protein-coupled receptor; hyperreactivity; beta-arrestin; extracellular signal-regulated kinase



Address for reprint requests and other correspondence: E. Clauser, Institut Cochin, Département d'Endocrinologie, Faculté de Médecine Cochin Port Royal, 24 rue du Faubourg Saint Jacques, 75014 Paris, France (E-mail: clauser{at}cochin.inserm.fr)




This article has been cited by other articles:


Home page
J EndocrinolHome page
J Manolopoulou, M Bielohuby, S J Caton, C E Gomez-Sanchez, I Renner-Mueller, E Wolf, U D Lichtenauer, F Beuschlein, A Hoeflich, and M Bidlingmaier
A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum
J. Endocrinol., February 1, 2008; 196(2): 215 - 224.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.